mild® removes a major root cause of lumbar spinal stenosis (LSS) to improve back and leg pain.
mild® for Patients
An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
mild® for Healthcare Professionals
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
This Pain Awareness Month, we’re bringing knowledge to both patients and providers on the effects of chronic low back pain (CLBP).
The first-ever Mobility Index, introduced as part of the Know Your Back Story campaign, was developed with data from the Harris Poll’s “Mobility Matters: Landmark Survey on Chronic Low Back Pain in America” to demonstrate how people should be moving through the decades of their lives without CLBP.*
Learn more about using the Mobility Index to show patients how their mobility measures up at the #linkinbio.
*"Mobility Matters" Harris Poll data at the #linkinbio.
The launch of our Know Your Back Story National Health Awareness Campaign over the summer was a huge success, and we want to thank everyone who made it possible! The east coast tour is done, but we are just getting started on our mission to increase patient and referral education awareness of the enlarged ligament as a cause of chronic low back pain (CLBP).
We’d like to especially recognize the dedicated healthcare professionals who joined us in educating the public about CLBP, the importance of looking for the enlarged ligament, and potential treatment options like the Mild Procedure. Many thanks to: @pain4eemd, @anjumbux, @btdurnkindo, Dr. Dan Kendall, @apmwellness, @dsayed123, @nvadvancedpain, Kelsey Kimball, PA, @kiranpatelmd, @ansky5121, Dr. Kunal Sood, @lindsayandmolly, @ladypaindoc, Dr. Mark Coleman, @_dr.azeem, @drpryz, @sanjayshahmd, @stangolovac, Dr. Steve Aydin, @steven_falowski, @timdeer30a, Dr. Wade Wong, and Dr. Youssef Josephson.
Check out the latest issue of Health is Action, featuring Dr. @kiranpatelmd on pages 12-13. Thank you Dr. Patel for bringing awareness to lumbar spinal stenosis (#LSS) and treatment options available, such as the Mild Procedure, to help patients find lasting relief.
View the article at the #linkinbio.
Learn more about LSS and the enlarged ligament at www.knowyourbackstory.com.
Find your place on Team Vertos! With new positions available, we are excited to add to our growing team. Join us on our mission to help lumbar spinal stenosis (#LSS) patients get on the path to lasting relief.
View current openings available throughout the U.S. at the #linkinbio.
Vertos Medical is an Equal Employment Opportunity employer.
According to new data, 76% of chronic low back pain (CLBP) patients have trouble completing everyday tasks.*
In recognition of Pain Awareness Month, we’re sharing key insights from the “Mobility Matters: Landmark Survey on Chronic Low Back Pain in America” conducted by The Harris Poll to help patients and providers learn more about CLBP.
Discover why leading interventionalists offer the Mild Procedure to treat lumbar spinal stenosis (#LSS), and how this gold standard of care can help patients find the relief they deserve. Learn more at the #linkinbio.
*"Mobility Matters" Harris Poll data at the #linkinbio.
September is Pain Awareness Month. Are your patients aware of what’s causing their lumbar spinal stenosis (#LSS)?
According to data from the “Mobility Matters: Landmark Survey on Chronic Low Back Pain in America” conducted by The Harris Poll, 37% of self-reported chronic low back pain (CLBP) patients have never been told by a healthcare professional (HCP) what’s causing their pain.*
By creating referral networks and keeping local primary care physicians informed about treatment options, you can help get more patients on the path to lasting relief.
*View "Mobility Matters" Harris Poll data at the #linkinbio.
Help your lumbar spinal stenosis (#LSS) patients, even those with comorbidities, by removing a major root cause of their lower back and leg pain associated with neurogenic claudication.
As an outpatient procedure that can be performed using local anesthetic and light sedation, the Mild Procedure can help a broad spectrum of LSS patients, including those who are not candidates for other therapies or are unable to tolerate surgery.
Learn more and view clinical data at the #linkinbio.
As an Advanced Practice Provider (APP), how can you make Mild patient education more personal? With the new Mild Procedure Patient Brochure, we’ve included helpful sections that make it easier than ever to show patients exactly how their lumbar spinal stenosis (#LSS) is compressing the nerves in their lower back. Additionally, patient-friendly charts and graphics can help you easily explain why you recommend the Mild Procedure as a first line therapy for LSS.
Ready to take your provider-patient communication to the next level? Be sure to view our recent blog article, and watch APP @acomer3 provide step-by-step tips that can help you drive success with Mild.
Advanced Practice Providers (APPs): Join our Mild Network! Check out our APP-specific educational content including our Imaging Webinar, tips on identifying and educating Mild patients, the common signs of epidural steroid injection (ESI) exhaustion, and much more at our blog at the #linkinbio.
Connect with us online at mildAPP.com to stay up to date on the latest from Vertos Medical.
As part of Vertos Medical’s mission to help more patients gain access to the Mild Procedure, we’re headed to the @wippain Conference in Budapest. If you or a healthcare provider you know is attending, please stop by the Vertos booth. We look forward to meeting new friends and future Mild providers!
Look for the ligament, it's a common problem, even in patients with comorbidities. Remove the problem with Mild and leave nothing behind.
New data from The Harris Poll shows that an estimated 72.3 million U.S. adults suffer from chronic low back pain (CLBP), higher than previously reported, and greater than arthritis, diabetes, or heart disease.
The survey also revealed that more awareness is needed to help patients suffering from CLBP understand the causes of their condition and reclaim their quality of life.
Read more about the Mobility Matters landmark survey results and find out how you can help more patients at the #linkinbio.
Advanced Practice Providers (#APPs): Ready to take your provider-patient communication to the next level? Be sure to view, “Creating your Mild Talk Track: 3 Simple Steps APPs can take today to enhance Patient Education.” The recent blog featuring APP @acomer3 includes step-by-step guidance on how you can use the Mild Patient Brochure most effectively, peer-led video demonstrations, and additional tips & resources to help facilitate your consultations.
Help your lumbar spinal stenosis (#LSS) patients understand their condition and get on the path to lasting relief.
Follow the data! The Pain Medicine journal recently published the Level 1 MOTION Study 1-year results highlighting the superiority of the Mild Procedure in combination with conventional medical management (CMM) over the use of CMM alone for patients with lumbar spinal stenosis (#LSS) suffering from neurogenic claudication (NC).
Review the complete findings and hear principal investigator, Dr. @timdeer30a, discuss why Mild is effective as an early interventional therapy for LSS at the #linkinbio.
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.
Mobility Matters: Low Back Pain in America, Harris Poll Survey, 2022. View data and full summary at knowyourbackstory.com.